EcoDrugPlus

Ensembl ID : ENSLCRG00005012174
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSLCRG00005014509
Gene Symbol: -
Cross references: -
219 Possible Orthologues:

Ensembl ID : ENSLCRG00005018321
Gene Symbol: -
Cross references: -
247 Possible Orthologues:

Ensembl ID : ENSLCRG00005009882
Gene Symbol: -
Cross references: -
374 Possible Orthologues:

Ensembl ID : ENSLCRG00005009880
Gene Symbol: -
Cross references: -
392 Possible Orthologues:

Ensembl ID : ENSLCRG00005009878
Gene Symbol: -
Cross references: -
392 Possible Orthologues:

Ensembl ID : ENSLCRG00005008663
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSLCRG00005001885
Gene Symbol: -
Cross references: -
386 Possible Orthologues:

Ensembl ID : ENSLCRG00005009870
Gene Symbol: -
Cross references: -
392 Possible Orthologues:

Ensembl ID : ENSLCRG00005009876
Gene Symbol: -
Cross references: -
392 Possible Orthologues:

Ensembl ID : ENSLCRG00005009872
Gene Symbol: -
Cross references: -
392 Possible Orthologues:

Ensembl ID : ENSLCRG00005023923
Gene Symbol: -
Cross references: -
184 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).